Onyx Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
11 March 2009 - 7:05AM
PR Newswire (US)
EMERYVILLE, Calif., March 10 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
present at the Cowen and Company 29th Annual Health Care Conference
on Tuesday, March 17, at 11:00 a.m. Eastern Time. Interested
parties may access a live webcast of the presentation on our
website at: http://www.onyx-pharm.com/wt/page/event_calendar It is
recommended that listeners log on 15 minutes early in order to
register and download any necessary software. For those unable to
participate during the live webcast, a recorded replay of the
presentation will be available within 24 hours of the completion of
the presentation through April 17, 2009. Onyx Pharmaceuticals, Inc.
is a biopharmaceutical company committed to improving the lives of
people with cancer by changing the way cancer is treated(TM). The
company, in collaboration with Bayer HealthCare Pharmaceuticals,
Inc., is developing and marketing Nexavar(R), a small molecule
drug. Nexavar is currently approved for the treatment of liver
cancer and advanced kidney cancer. Additionally, Nexavar is being
investigated in several ongoing trials in non-small cell lung
cancer, melanoma, breast cancer, and other cancers. For more
information about Onyx, visit the company's website at
http://www.onyx-pharm.com/. Nexavar(R) (sorafenib) tablets is a
registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alex Santos of Onyx
Pharmaceuticals, Inc., +1-510-597-6504 Web Site:
http://www.onyx-pharm.com/
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals (MM) News Articles